noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

D-Wave Quantum Inc.

Notice of Proposed Sale of Securities (Form 144)
NEMA – Nebraska Emergency[...]

Gov. Pillen Declares Emergency, Mobilizes Guard as Wildfires Burn in[...]
The University of New Mexico

UNM recognized for second consecutive year by Arbor Day Foundation[...]

Healthcare

Avanos Medical Inc.

03/12/2026 | Press release | Distributed by Public on 03/12/2026 14:39

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 6, 2026, the Board of Directors of Avanos Medical, Inc. (the "Company") increased the target value of the annual long-term incentive grant to which David C. Pacitti, the Company's Chief Executive Officer, is eligible under the Company's 2021 Long Term Incentive Plan, as amended, from $5,000,000 to $5,500,000, effective beginning in 2026.

Avanos Medical Inc. published this content on March 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 12, 2026 at 20:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]